CD274 and breast carcinoma: PD-1/PD-L1 interactions were also reported in breast cancer, and the expression of PD-1/PD-L1 was confirmed to be closely related to the effect of checkpoint inhibitors (Mittendorf et al., 2015; Salatino et al., 2018; Zhu et al., 2018).